New cancer cell research opens a new avenue for understanding how tumors spread to other tissues via metastasis, and hints at novel ways to block the spread of cancer by targeting the process.
Three distinguished Weill Cornell Medicine physician-scientists, Dr. Joseph J. Fins, Dr. Rainu Kaushal and Dr. Shahin Rafii, have been elected to the Association of American Physicians.
Among participants who had hepatitis C and who injected drugs, those treated at a non-stigmatizing “accessible care” treatment center co-located with a syringe service program were nearly three times more likely to be cured, according to new research.
The SARS-CoV-2 virus can infect specialized pacemaker cells that maintain the heart’s rhythmic beat, setting off a self-destruction process within the cells, according to a preclinical study co-led by researchers at Weill Cornell Medicine, NewYork-Presbyterian and NYU Grossman School of Medicine.
Researchers at Weill Cornell Medicine have identified a key protein that induces the program to build specialized liver blood vessels. The discovery could lead to engineered replacement hepatic tissue to treat common liver diseases.
With the Hudson River rising from a fast-warming climate, the cities and towns along its banks now have an opportunity to save and reimagine their municipal waterfronts.
A Cornell collaboration crossing medicine, law, technology and communication is aiming to encourage the use of health care benefits by refugees in the U.S. – who often suffer poor health but are using these entitlements less than they have in the past.
An analysis of newly released census data by the Cornell Program on Applied Demographics shows how the pandemic’s onset influenced populations in each New York state county.
